307830
Influenza Vaccine Uptake in a Midwest County: A Collaborative Study
This descriptive cross sectional study was conducted with a convenience sample of 1298 residents. Data collection by nursing students at grocery stores and churches, and through online surveys at schools and local businesses occurred over a seven-day period. The majority of the sample was 45-64 years (43%), Caucasian (82%), and female (65%).
Data indicated 45% of those surveyed received the flu vaccine this season. Chi square analysis demonstrated a significant (all ps ≤ .01) association between receiving the vaccine and age, race, and income. Of those not receiving the vaccine, the most frequent concern was about side effects (16%). Chi square analysis demonstrated a significant (all ps < .001) association between concern about side effects and age, race, and gender.
The data assists local public health officials and health care providers to create targeted vaccine outreach campaigns. Knowledge gained through collaboration will facilitate further work between the university and health department professionals. Results and recommendations for future research will be discussed.
Learning Areas:
Assessment of individual and community needs for health educationPublic health or related nursing
Learning Objectives:
Identify barriers to flu vaccine uptake among different subgroups in a population.
Identify the benefits of a health department-university collaboration.
Keyword(s): Community-Based Partnership & Collaboration, Public Health Research
Qualified on the content I am responsible for because: I received a PHD in 2006 and NIH-NINR Postdoctoral Fellowship Training in Behavioral Nursing Research in 2007. I have taught community health nursing and currently teach epidemiology for graduate nursing students. My interests include physical activity,health promotion, perceived health, chronic kidney disease, and physical function.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.